Projected Income Statement: Orange

Forecast Balance Sheet: Orange

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 24,269 25,298 27,002 22,482 22,526 38,608 37,556 35,549
Change - 4.24% 6.74% -16.74% 0.2% 71.39% -2.72% -5.34%
Announcement Date 2/17/22 2/16/23 2/15/24 2/13/25 2/18/26 - - -
1EUR in Million
Estimates

Cash Flow Forecast: Orange

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
CAPEX 1 7,660 7,371 6,815 6,425 6,208 7,086 7,399 7,292
Change - -3.77% -7.54% -5.72% -3.38% 14.14% 4.43% -1.44%
Free Cash Flow (FCF) 1 3,576 3,864 5,239 3,770 4,572 4,202 4,998 5,456
Change - 8.05% 35.58% -28.04% 21.27% -8.1% 18.94% 9.16%
Announcement Date 2/17/22 2/16/23 2/15/24 2/13/25 2/18/26 - - -
1EUR in Million
Estimates

Forecast Financial Ratios: Orange

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

        
EBITDA Margin (%) 29.55% 29.82% 29.54% 30.08% 30.87% 32.04% 32.66% 33.24%
EBIT Margin (%) 18.74% 13.67% 12.71% 13.63% 11.31% 13.58% 14.06% 14.42%
EBT Margin (%) 4.09% 8.93% 8.53% 10.57% 5.47% 10.37% 10.27% 10.95%
Net margin (%) 0.55% 4.94% 5.53% 5.84% 1.33% 5.8% 6.17% 6.77%
FCF margin (%) 8.41% 8.89% 11.87% 9.36% 11.32% 9.35% 10.19% 10.93%
FCF / Net Income (%) 1,534.76% 180.06% 214.71% 160.43% 849.81% 161.15% 165.27% 161.41%

Profitability

        
ROA 0.22% 1.97% 2.22% 2.2% 0.51% 1.67% 1.9% 2.12%
ROE 6.1% 6.69% 7.67% 7.39% 1.75% 8.9% 8.98% 10.05%

Financial Health

        
Leverage (Debt/EBITDA) 1.93x 1.95x 2.07x 1.86x 1.81x 2.68x 2.35x 2.14x
Debt / Free cash flow 6.79x 6.55x 5.15x 5.96x 4.93x 9.19x 7.51x 6.52x

Capital Intensity

        
CAPEX / Current Assets (%) 18.01% 16.96% 15.45% 15.96% 15.37% 15.77% 15.09% 14.61%
CAPEX / EBITDA (%) 60.96% 56.86% 52.28% 53.06% 49.78% 49.23% 46.2% 43.97%
CAPEX / FCF (%) 214.21% 190.76% 130.08% 170.42% 135.78% 168.64% 148.05% 133.67%

Items per share

        
Cash flow per share 1 4.228 4.182 4.531 3.833 4.052 4.361 4.979 5.048
Change - -1.09% 8.35% -15.4% 5.72% 7.61% 14.19% 1.37%
Dividend per Share 1 0.7 0.7 0.7 0.72 0.75 0.7872 0.8196 0.8513
Change - 0% 0% 2.86% 4.17% 4.96% 4.11% 3.87%
Book Value Per Share 1 12.16 11.96 11.97 11.95 11.19 11.64 12.23 12.62
Change - -1.66% 0.1% -0.14% -6.39% 4.02% 5.11% 3.15%
EPS 1 - 0.73 0.85 0.82 0.14 1.034 1.12 1.226
Change - - 16.44% -3.53% -82.93% 638.52% 8.29% 9.53%
Nbr of stocks (in thousands) 2,631,971 2,657,122 2,659,182 2,658,153 2,658,600 2,659,283 2,659,283 2,659,283
Announcement Date 2/17/22 2/16/23 2/15/24 2/13/25 2/18/26 - - -
1EUR
Estimates
2026 *2027 *
P/E 15.3x 14.2x
PBR 1.36x 1.3x
EV / Sales 1.8x 1.63x
Yield 4.96% 5.17%

EPS & Dividend

Y-o-Y evolution of P/E

Year-on-year evolution of the Yield

Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
15.86EUR
Average target price
19.04EUR
Spread / Average Target
+20.02%

Quarterly revenue - Rate of surprise